{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:08:45Z","timestamp":1748664525575,"version":"3.41.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Clinical experience and patient-level physiological studies indicate that albuterol transiently reduces oxygen saturation, irrespective of the underlying respiratory condition causing the wheezing. Three revisions of the Cochrane review, Bronchodilators for Bronchiolitis (Review), have found that albuterol temporarily increases oxygen saturation. Rarely, these findings were even statistically significant, but the direction of effect is consistently opposite from physiological studies. In this study, we attempted to resolve this apparent paradox.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The original trial publications included in multiple oxygen saturation sub-analyses in the 2006, 2010, and 2014 updates of the Cochrane review were assessed for appropriate study inclusion, correctness of calculations, and correct analysis with respect to direction of effect. The studies were also reviewed to assess whether the data was correctly transferred to the meta-analysis software. We repeated the meta-analyses calculations after correcting for suspected errors and plotted the results of the meta-analyses as originally reported and in their corrected form on an albatross plot.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We found data miscalculations, errors of transposition of albuterol and placebo data, the inclusion of inpatient data in outpatient analyses, and questionable study inclusions in the 3 Cochrane review updates. After corrections were made, the direction of effect of albuterol switched negative, albeit nonsignificantly, a finding most consistent with clinical and physiological observations. In addition, the very wide heterogeneity between the original meta-analyses disappeared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>After multiple suspected data flaws were corrected our reanalyses of the reported data confirmed that decreased oxygen saturation can be expected following administration of albuterol to infants presenting with bronchiolitis syndrome, thereby resolving the apparent paradox in favor of clinical observation and research physiology.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000003352","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T14:01:00Z","timestamp":1740405660000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Oxygen Saturation Sub-analyses Errors in the Dominant Meta-analysis Used to Deimplement Albuterol as a Therapeutic Option for Bronchiolitis"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0425-1320","authenticated-orcid":false,"given":"Larry","family":"Mellick","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Augusta University, Augusta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Weston","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Augusta University, Augusta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Walsh","sequence":"additional","affiliation":[{"name":"Sutter Medical Center, Sacramento, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"McKinney","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Mississippi, Jackson, MS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Data Science and Epidemiology, Augusta University, Augusta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"R1-20250530","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0970-2113.197116","article-title":"Mechanisms of hypoxemia","volume":"34","author":"Sarkar","year":"2017","journal-title":"Lung India Off Organ Indian Chest Soc"},{"key":"R2-20250530","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/thx.44.4.258","article-title":"Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen","volume":"44","author":"Ballester","year":"1989","journal-title":"Thorax"},{"key":"R3-20250530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/jappl.1991.70.1.405","article-title":"Influence of bronchial arterial PO2 on pulmonary vascular resistance","volume":"70","author":"Marshall","year":"1991","journal-title":"J Appl Physiol"},{"key":"R4-20250530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00041.2010","article-title":"Hypoxic pulmonary vasoconstriction","volume":"92","author":"Sylvester","year":"2012","journal-title":"Physiol Rev"},{"key":"R5-20250530","doi-asserted-by":"crossref","first-page":"e1008861","DOI":"10.1371\/journal.pcbi.1008861","article-title":"Hypoxic pulmonary vasoconstriction as a regulator of alveolar-capillary oxygen flux: a computational model of ventilation-perfusion matching","volume":"17","author":"Marquis","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"R6-20250530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1580\/1080-6032(2004)015[0032:IOHPVP]2.0.CO;2","article-title":"Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats","volume":"15","author":"Berg","year":"2004","journal-title":"Wilderness Environ Med"},{"key":"R7-20250530","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/13993003.01753-2015","article-title":"Hypoxic pulmonary vasoconstriction: clinical implications","volume":"47","author":"Hughes","year":"2016","journal-title":"Eur Respir J"},{"key":"R8-20250530","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.pcad.2010.03.001","article-title":"Prevention and treatment of high-altitude pulmonary edema","volume":"52","author":"Maggiorini","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"R9-20250530","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00003072-199410000-00014","article-title":"Scintigraphic appearance of albuterol-induced inhibition of hypoxic pulmonary vasoconstriction","volume":"19","author":"Worsley","year":"1994","journal-title":"Clin Nucl Med"},{"key":"R10-20250530","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.1995.tb04552.x","article-title":"Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers","volume":"40","author":"Kiely","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"R11-20250530","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/bmj.323.7304.98","article-title":"Oxygen treatment for acute severe asthma","volume":"323","author":"Inwald","year":"2001","journal-title":"BMJ"},{"key":"R12-20250530","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1164\/rccm.201209-1739PP","article-title":"\u03b22-agonist therapy in lung disease","volume":"187","author":"Cazzola","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20250530","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001266.pub4","article-title":"Bronchodilators for bronchiolitis","author":"Gadomski","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20250530","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/adc.66.9.1061","article-title":"Effect of salbutamol on oxygen saturation in bronchiolitis","volume":"66","author":"Ho","year":"1991","journal-title":"Arch Dis Child"},{"key":"R17-20250530","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1378\/chest.86.6.868","article-title":"Arterial oxygen desaturation following salbutamol inhalation in acute asthma","volume":"86","author":"Tal","year":"1984","journal-title":"Chest"},{"key":"R18-20250530","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/PEC.0000000000003049","article-title":"The de-implementation of bronchiolitis medications: is it time for a moratorium?","volume":"40","author":"Mellick","year":"2024","journal-title":"Pediatr Emerg Care"},{"key":"R19-20250530","doi-asserted-by":"crossref","first-page":"e27391","DOI":"10.1002\/ppul.27391","article-title":"Outpatient medications deimplemented by the AAP Bronchiolitis Guidelines: an umbrella review of meta-analyses","volume":"60","author":"Mellick","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"R20-20250530","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ppul.20260","article-title":"Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis","volume":"40","author":"Ralston","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"R21-20250530","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jrsm.1239","article-title":"The albatross plot: a novel graphical tool for presenting results of diversely reported studies in a systematic review","volume":"8","author":"Harrison","year":"2017","journal-title":"Res Synth Methods"},{"key":"R22-20250530","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ppul.21108","article-title":"High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis","volume":"45","author":"Anil","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"R23-20250530","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pupt.2011.09.004","article-title":"The efficacy of nebulized salbutamol, hypertonic saline and salbutamol\/hypertonic saline combination in moderate bronchiolitis","volume":"24","author":"Ipek","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"R24-20250530","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3476(94)70269-1","article-title":"Oral versus nebulized albuterol in the management of bronchiolitis in Egypt","volume":"124","author":"Gadomski","year":"1994","journal-title":"J Pediatr"},{"issue":"6 Pt 1","key":"R25-20250530","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1542\/peds.93.6.907","article-title":"Efficacy of albuterol in the management of bronchiolitis","volume":"93","author":"Gadomski","year":"1994","journal-title":"Pediatrics"},{"key":"R27-20250530","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/pch\/19.9.485","article-title":"Canadian Paediatric Society, Acute Care Committee, Drug Therapy and Hazardous Substances Committee. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age","volume":"19","author":"Friedman","year":"2014","journal-title":"Paediatr Child Health"},{"issue":"suppl 1","key":"R29-20250530","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jiu828","article-title":"Challenges and opportunities in developing respiratory syncytial virus therapeutics","volume":"211","author":"Sim\u00f5es","year":"2015","journal-title":"J Infect Dis"},{"key":"R30-20250530","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"key":"R31-20250530","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/317655","article-title":"Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997","volume":"183","author":"Shay","year":"2001","journal-title":"J Infect Dis"},{"issue":"2 Suppl","key":"R32-20250530","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/01.inf.0000053884.21238.13","article-title":"Selected populations at increased risk from respiratory syncytial virus infection","volume":"22","author":"Meissner","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20250530","doi-asserted-by":"crossref","first-page":"e2339884","DOI":"10.1001\/jamanetworkopen.2023.39884","article-title":"Admissions for bronchiolitis at children\u2019s hospitals before and during the COVID-19 pandemic","volume":"6","author":"Remien","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R34-20250530","doi-asserted-by":"crossref","first-page":"e2416852","DOI":"10.1001\/jamanetworkopen.2024.16852","article-title":"Pediatric respiratory syncytial virus hospitalizations and respiratory support after the COVID-19 pandemic","volume":"7","author":"Winthrop","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R35-20250530","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1152\/jappl.1967.22.3.402","article-title":"An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects","volume":"22","author":"Knudson","year":"1967","journal-title":"J Appl Physiol"},{"key":"R36-20250530","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-6749(72)90057-7","article-title":"Comparison of the effect on blood gases, ventilation, and perfusion of isoproterenol-phenylephrine and salbutamol aerosols in chronic bronchitis with asthma","volume":"49","author":"Harris","year":"1972","journal-title":"J Allergy Clin Immunol"},{"key":"R37-20250530","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/thx.28.5.592","article-title":"Comparison of cardiorespiratory effects of terbutaline and salbutamol aerosols in patients with reversible airways obstruction","volume":"28","author":"Harris","year":"1973","journal-title":"Thorax"},{"key":"R38-20250530","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12874-021-01269-y","article-title":"Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews","volume":"21","author":"Lunny","year":"2021","journal-title":"BMC Med Res Methodol"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:00:58Z","timestamp":1748617258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000003352","relation":{},"ISSN":["0749-5161","1535-1815"],"issn-type":[{"type":"print","value":"0749-5161"},{"type":"electronic","value":"1535-1815"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"2024-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}